Incidence Rate of Type 2 Diabetes Mellitus after Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of 170,139 Women

被引:140
作者
Li, Zhuyu [1 ]
Cheng, Yunjiu [2 ]
Wang, Dongyu [1 ]
Chen, Haitian [1 ]
Chen, Hanqing [1 ]
Ming, Wai-kit [1 ]
Wang, Zilian [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynaecol, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
ABNORMAL GLUCOSE-TOLERANCE; LONG-TERM RISK; INTERNATIONAL ASSOCIATION; PREGNANCY; DIAGNOSIS; PREVALENCE; HISTORY; CLASSIFICATION; HYPERGLYCEMIA; PREDICTORS;
D O I
10.1155/2020/3076463
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The reported incidence of type 2 diabetes mellitus (T2DM) after gestational diabetes (GDM) varies widely. The purpose of this meta-analysis was to define the incidence rate of T2DM among women with a history of GDM and to examine what might modulate the rate. Research Design and Methods. We searched PubMed and Embase for terms related to T2DM after GDM up to January 2019. Large cohort studies with sample size >= 300 and follow-up duration of at least one year were included. Data from selected studies were extracted, and meta-analysis was performed using the random-effects model. Subgroups analyses were based on the sample size of gestational diabetes, geographic region, maternal age, body-mass index, diagnostic criteria, and duration of follow-up. Results. Twenty-eight studies involving 170,139 women with GDM and 34,627 incident cases of T2DM were identified. The pooled incidence of T2DM after GDM was 26.20 (95% CI, 23.31 to 29.10) per 1000 person-years. Women from Asia and those with older age and higher body mass index seem to experience higher risk of developing T2DM. The incidence rate of T2DM was lowest when applying IADPSG (7.16 per 1000 person-years) to diagnose GDM. The risk of developing T2DM after GDM increased linearly with the duration of follow-up. The increments per year of follow-up were estimated at 9.6 parts per thousand. The estimated risks for T2DM were 19.72% at 10 years, 29.36% at 20 years, 39.00% at 30 years, 48.64% at 40 years, and 58.27% at 50 years, respectively. Conclusions. The findings of very high incidence of T2DM after GDM add an important insight into the trajectory of the development of T2DM in the long-term postpartum periods, which could provide evidence for consultant and might motivate more women with GDM to screen for T2DM. This trial is registered with PROSPERO identifier CRD42019128980.
引用
收藏
页数:12
相关论文
共 65 条
  • [1] EFFECTS OF HYPOGLYCEMIA AND HYPERGLYCEMIA ON PREGNANCY OUTCOME
    ABELL, DA
    BEISCHER, NA
    [J]. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1976, 16 (02) : 75 - 81
  • [2] Low uptake of postpartum screening for Type 2 diabetes in women after a diagnosis of gestational diabetes
    Adekojo, O.
    Revell, K. R.
    Preece, H.
    Morris, S.
    Coleman, M. A.
    Holt, R. I. G.
    [J]. DIABETIC MEDICINE, 2016, 33 (11) : 1599 - 1601
  • [3] Diabetes and abnormal glucose tolerance in women with previous gestational diabetes
    Albareda, M
    Caballero, A
    Badell, G
    Piquer, S
    Ortiz, A
    de Leiva, A
    Corcoy, R
    [J]. DIABETES CARE, 2003, 26 (04) : 1199 - 1205
  • [4] Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
  • [5] 2-S
  • [6] Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI [10.2337/dc11-S011, 10.2337/dc14-S081, 10.2337/dc12-s011, 10.2337/dc13-S011, 10.2337/dc10-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S062]
  • [7] American Diabetes Association, 2019, Clin Diabetes, V37, P11, DOI 10.2337/cd18-0105
  • [8] Use of healthcare resources after gestational diabetes mellitus: A longitudinal case-control analysis
    Anderberg, Eva
    Carlsson, Katarina Sten
    Berntorp, Kerstin
    [J]. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2012, 40 (04) : 385 - 390
  • [9] [Anonymous], 1985, World Health Organ Tech Rep Ser, V727, P1
  • [10] [Anonymous], 1985, Diabetes Care, V34, P123